study objectives assess frequencies polymorphisms amino acid positions NUMBER NUMBER NUMBER beta2ar gene effects copd patients design prospective study patients patients copd NUMBER healthy subjects included measurements polymorphisms coding block delineated using polymerase chain reaction pcr approach pcr technique verified direct dideoxy sequencing pcr products pulmonary function tests performed patients results arg16 polymorphism prevalent copd patients healthy populations p NUMBER significant correlation p NUMBER gln27 polymorphism fev1 percent predicted value patients gln27 polymorphism higher percentage low fev1 percent predicted did patients glnglu gluglu variants conclusions polymorphism gly16 increase patients susceptibility development copd gln27 polymorphism associated severity copd chinese population beta2 adrenoceptor case control beta2 ar allele specific allele specific beta2 ar beta2 ar beta2 ar